Open-label pitolisant
HBS-101-CL-010
Phase 3 small_molecule completed
Quick answer
Open-label pitolisant for Idiopathic Hypersomnia is a Phase 3 program (small_molecule) at Harmony Biosciences Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Harmony Biosciences Holdings
- Indication
- Idiopathic Hypersomnia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed